
About Zosano Pharma
Zosano Pharma was a Healthcare company based in Fremont (United States) founded in 2006. It develops innovative transdermal drug delivery technologies for various therapeutic applications. It operates on a B2B model. Zosano Pharma has raised $147.16 million across 13 funding rounds from investors including Nomura, Trinity Cap and HBM Healthcare Investments. The company has 40 employees. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Delivery and Transdermal Systems. Its legal entity is ZOSANO PHARMA CORPORATION. Its competitors include Kriya Therapeutics, Sana Biotechnology and Semma Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Fremont, United States
- Employees 40
- Stage Public
- SectorsHealthcare
- Website zosanopharma.com
- Legal Name Zosano Pharma Corporation
- Total Equity Funding$147.16M (USD)
in 13 rounds
- Latest Funding Round$14M (USD), Debt – Venture
Sep 2018
- InvestorsNomura
& 5 more
- Employee Count40
Funding Insights of Zosano Pharma
Zosano Pharma has successfully raised a total of $147.16M across 13 strategic funding rounds. The most recent funding activity was a Debt β Venture round of $14 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $147.16M
- Total Rounds 13
- Last Round Debt – Venture β $14M
- First Round $90M
(Nov 2007)
- Investors Count 6
Latest 10 of 13 funding rounds of Zosano Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $14M | Debt – Venture | β | β | |
| Jun 2018 | Post-IPO | β | β | ||
| Aug 2016 | $7.54M | Post-IPO | β | β | β |
| Jan 2015 | $15M | Post-IPO | β | β | β |
| Dec 2014 | $1.33M | Series B | β | β | β |
| Feb 2014 | $3.1M | Series B | β | β | β |
| Nov 2013 | $365,000 | Series B | β | β | β |
| Sep 2013 | $3.03M | Series B | β | β | β |
| Sep 2011 | $4.71M | Series B | β | β | β |
| Aug 2010 | $3.11M | Series B | β | β | β |
6 investors in total: 6 institutional.
Investors in Zosano Pharma
Zosano Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Nomura, Trinity Cap and HBM Healthcare Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt and equipment financing are provided to growth-stage companies. | 2008 | trinitycap.com | Phoenix, United States | |
PE firm investing in the US | aislingcapital.com | New York, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
| proquestvc.com | ||||
Life sciences focused VC firm funding companies in the US and Europe | 2001 | hbmhealthcare.com | Zug, Switzerland | |
Diversified asset management services are offered globally by the firm. | 1925 | nomura.com | Chuo City, Japan |
Investor details for Zosano Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Zosano Pharma
14 people are tracked at Zosano Pharma (7 in leadership, 7 in team); the tracked headcount is 40.
| Name | Role | Group |
|---|---|---|
Kristina Warga | VP, Corporate Controller | Leadership |
Mahmoud Ameri | VP, Research & Development | Leadership |
Christine Matthews | CFO | Leadership |
Donald Kellerman | VP, Clinical Development & Medical Affairs | Leadership |
Brian Minh Nguyen | Director, Financial Planning & Analysis | Leadership |
Lu Liu | VP, Technical Operations | Leadership |
Jim Mellers | Associate Director Equipment Engineering Maintenance | Leadership |
Michael Magnano | Senior Project Manager | Team |
Jessica Heasley | System Design Engineer | Team |
Michael Abriam | Manufacturing | Team |
Julie Davilla | Manager, Process Development | Team |
Amy Khuu | Senior QA Specialist | Team |
Trong Nguyen | Manager | Team |
Phuong Nguyen | Materials Handler . 3rd | Team |
Complete people profiles for Zosano Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Zosano Pharma
4 dated milestones of Zosano Pharma across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Zosano Pharma is founded.
- Funding First funding round of $90.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt β Venture, of $14.0M.
Competitors of Zosano Pharma
Zosano Pharma has 3 listed competitors in our database, 3 of them funded. They include Kriya Therapeutics, Sana Biotechnology and Semma Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kriyatherapeutics.com | 2012 | Redwood, United States | $930.93M | 159 | Developer of therapeutic solutions for the treatment of diabetes | |
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| semma-tx.com | 2015 | Cambridge, United States | $158M | 58 | Provider of bio-artificial pancreas for Type 1 Diabetes treatment |
Detailed competitors of Zosano Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as Zosano Pharma (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zosano Pharma
Complete news archive for Zosano Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zosano Pharma
Zosano Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Zosano Pharma is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Zosano Pharma is a funded company, having raised a total of $147.16M across 13 funding rounds to date. The company's 1st funding round was a Series B of $3.11M, raised on Nov 2007.
Zosano Pharma has 40 employees.
Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Zosano Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Kriya Therapeutics.
Zosano Pharma has 6 investors. Key investors include Nomura, Trinity Cap, HBM Healthcare Investments, Aisling Capital, and NEA.
Zosano Pharma operates through Zosano Pharma Corporation.
